| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327] |
|---|
| Ligand | BDBM333146 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Biochemical binding TR-FRET assay |
|---|
| IC50 | 67.0±n/a nM |
|---|
| Citation |  Hird, A; Belmonte, M; Yang, W; Secrist, P; Robbins, D; Kazmirski, S; Wu, D; Peng, B; Johannes, J; Lamb, M; Ye, Q; Zheng, X Mcl-1 inhibitors and methods of use thereof US Patent US11472816 Publication Date 10/18/2022 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327] |
|---|
| Name: | Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327] |
|---|
| Synonyms: | BCL2L3 | Induced myeloid leukemia cell differentiation protein Mcl-1(171-327) | MCL1 | MCL1_HUMAN | Myeloid cell leukemia 1 (Mcl-1) |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 17896.13 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q07820[171-327] |
|---|
| Residue: | 157 |
|---|
| Sequence: | EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQG
MLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPL
AESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG
|
|
|
|---|
| BDBM333146 |
|---|
| n/a |
|---|
| Name | BDBM333146 |
|---|
| Synonyms: | Compound I | US10196404, Example 1 | US10196404, Example 2 | US10196404, Example 3 | US11472816, Example 3 | US11691989, Compound AZD5991 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C35H34ClN5O3S2 |
|---|
| Mol. Mass. | 672.259 |
|---|
| SMILES | Cc1c-2c(CSCc3cc(CSc4cc(OCCCc5c(C(O)=O)n(C)c6c-2c(Cl)ccc56)c2ccccc2c4)n(C)n3)nn1C |
|---|
| Structure | 
|
|---|
Search and Browse
